Todd C. Brady - Mar 30, 2022 Form 4 Insider Report for Aldeyra Therapeutics, Inc. (ALDX)

Role: President and CEO, Director
Signature: /s/ Todd C. Brady
Stock symbol: ALDX
Transactions as of: Mar 30, 2022
Transactions value $: $0
Form type: 4
Date filed: 4/1/2022, 07:44 PM
Previous filing: Jun 7, 2021
Next filing: Apr 28, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ALDX	Common Stock	Award	$0	+250K	+26.35%	$0.00	1.2M	Mar 30, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ALDX	Employee Stock Option (Right to Buy)	Award	$0	+250K		$0.00	250K	Mar 30, 2022	Common Stock	250K	$4.52	Direct	F2
transaction	ALDX	Bonus Units	Award	$0	+208K		$0.00	208K	Mar 30, 2022	Common Stock	208K	$4.52	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of common stock underlying a time-based restricted stock unit award (RSU). The RSU vests ratably in equal annual installments over a four-year period beginning on January 1, 2022, provided that the Reporting Person has provided continuous service to the Issuer through the applicable vesting date.
F2	The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2022.
F3	The bonus units vest in four (4) annual installments from the date of grant and entitle the Reporting Person to receive a cash payment, on the earlier of (i) four (4) years from the date of grant or (ii) a Change of Control of the Issuer (as defined in the grant documents), equal in value to the amount by which the then value of the Issuer's common stock exceeds the base value of $4.52.